CG
Carter Gould Cantor Fitzgerald Latest Price Targets & Analyst Ratings
Main Sector
Healthcare
Ratings Past Year
27
Avg Return
Past Year
Past Year
13%
Success Rate
Past Year
Past Year
0
%
Rating Distribution
Past Year
Positive
63%
Neutral
37%
Negative
0%
Past Week
Past Month
Past 3 Months
Past 6 Months
Past Year
All Time
Positive
Neutral
Negative
Mega Cap
Over $200B
Large Cap
$10B to $200B
Mid Cap
$2B to $10B
Small Cap
$250M to $2B
Micro Cap
Under $250M
Consumer Staples
Healthcare
Technology
Consumer Staples
Education & Training Services
Healthcare
Biotechnology
Drug Manufacturers - General
Drug Manufacturers - Specialty & Generic
Technology
Software - Application
| Stock | Rating | Price Target |
Upside Downside |
Ratings 1 Year |
Avg Return 1 Year |
Success Rate 1 Year | Date | |
|---|---|---|---|---|---|---|---|---|
|
Overweight
Maintained
| $155 |
8%
upside
| 3 | +12% |
0
%
| 11 Feb ‘26 24 days ago |
|
|
|
Overweight
Maintained
| $1,205 |
22%
upside
| 4 | +7.7% |
0
%
| 5 Feb ‘26 1 month ago |
|
|
|
Neutral
Reiterated
| $27 |
0%
downside
| 3 | – |
–
| 4 Feb ‘26 1 month ago |
|
|
|
Neutral
Maintained
| $120 |
4%
upside
| 2 | -29% |
–
| 4 Feb ‘26 1 month ago |
|
|
|
Neutral
Maintained
| $350 |
5%
downside
| 3 | – |
–
| 4 Feb ‘26 1 month ago |
|
|
|
Overweight
Maintained
| $800 |
5%
upside
| 3 | +11% |
0
%
| 2 Feb ‘26 1 month ago |
|
|
|
Overweight
Maintained
| $112 |
13%
upside
| 1 | +1.3% |
0
%
| 31 Oct ‘25 4 months ago |
|
|
|
Overweight
Maintained
| $245 |
6%
upside
| 2 | +17% |
0
%
| 15 Sep ‘25 5 months ago |
|
|
|
Overweight
Maintained
| $485 |
6%
upside
| 3 | -1.4% |
0
%
| 5 Aug ‘25 7 months ago |
|
|
|
Neutral
Reiterated
| $55 |
9%
downside
| 2 | +9.3% |
–
| 23 Apr ‘25 10 months ago |
|
|
|
Overweight
Initiated
| – | – | 1 | +95% |
0
%
| 22 Apr ‘25 10 months ago |
|